药物对比
Insulin Regular Human vs Sotagliflozin
比较常规人胰岛素与 sotagliflozin (Inpefa) 治疗糖尿病。胰岛素为注射用降糖药；sotagliflozin 为口服 SGLT 抑制剂，用于心血管保护。
此页面暂无可用的对比维度。
临床背景
This comparison occurs in type 2 diabetes with comorbid heart failure when deciding between intensifying insulin therapy or adding an SGLT inhibitor like sotagliflozin.
结论
Neither is universally better; regular human insulin is essential for insulin-deficient patients while sotagliflozin provides additional cardiovascular protection in type 2 diabetes.
全部药物对比